Nanalysis Scientific Corp (NSCI.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 1,154 | 1,152 | 1,091 | 1,133 | 1,216 |
| Income taxes - deferred | -8 | -24 | 985 | -134 | -245 |
| Accounts receivable | 879 | -853 | -3,443 | 9 | N/A |
| Other Working Capital | 848 | 1,936 | -1,546 | -310 | -772 |
| Other Operating Activity | -1,818 | -747 | 580 | -2,248 | -3,640 |
| Operating Cash Flow | $1,055 | $1,464 | $-2,333 | $-1,550 | $-3,441 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 34 | -49 | -112 | -6 | -211 |
| Net Acquisitions | N/A | N/A | -326 | 0 | -500 |
| Purchase Sale Intangibles | -500 | -529 | -746 | -598 | -1,521 |
| Other Investing Activity | 0 | 0 | -182 | -466 | -27 |
| Investing Cash Flow | $-466 | $-578 | $-1,366 | $-1,070 | $-2,259 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 0 | -2,902 | 2,902 | 0 | -4,949 |
| Debt Issued | 0 | 0 | 770 | -398 | 10,551 |
| Debt Repayment | -859 | -1,052 | -382 | -374 | -676 |
| Other Financing Activity | -298 | 4,003 | -103 | -290 | 3,971 |
| Financing Cash Flow | $-1,157 | $49 | $3,187 | $-1,062 | $8,897 |
| Beginning Cash Position | 1,694 | 759 | 1,271 | 4,953 | 1,756 |
| End Cash Position | 1,126 | 1,694 | 759 | 1,271 | 4,953 |
| Net Cash Flow | $-568 | $935 | $-512 | $-3,682 | $3,197 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,055 | 1,464 | -2,333 | -1,550 | -3,441 |
| Capital Expenditure | -501 | -578 | -857 | -604 | -1,732 |
| Free Cash Flow | 554 | 886 | -3,190 | -2,154 | -5,173 |